Difference between revisions of "Journal Club"
Line 1: | Line 1: | ||
{|class=wikitable style="text-align:center;" | {|class=wikitable style="text-align:center;" | ||
− | |+style="text-align:left;font-size:12pt" | 2022 | + | |+style="text-align:left;font-size:12pt" | 2022 scOmics |
|- | |- | ||
!scope="col" style="padding:.4em" | Date | !scope="col" style="padding:.4em" | Date | ||
Line 10: | Line 10: | ||
|style="padding:.4em;" rowspan=1|2022/09/15 | |style="padding:.4em;" rowspan=1|2022/09/15 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-28 |
|style="padding:.4em;"|G Geon | |style="padding:.4em;"|G Geon | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 17: | Line 17: | ||
|style="padding:.4em;" rowspan=1|2022/09/08 | |style="padding:.4em;" rowspan=1|2022/09/08 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-27 |
|style="padding:.4em;"|SB Baek | |style="padding:.4em;"|SB Baek | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 24: | Line 24: | ||
|style="padding:.4em;" rowspan=1|2022/09/01 | |style="padding:.4em;" rowspan=1|2022/09/01 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-26 |
|style="padding:.4em;"|JH Cha | |style="padding:.4em;"|JH Cha | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 31: | Line 31: | ||
|style="padding:.4em;" rowspan=1|2022/08/25 | |style="padding:.4em;" rowspan=1|2022/08/25 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-25 |
|style="padding:.4em;"|JW Yu | |style="padding:.4em;"|JW Yu | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 38: | Line 38: | ||
|style="padding:.4em;" rowspan=1|2022/08/18 | |style="padding:.4em;" rowspan=1|2022/08/18 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-24 |
|style="padding:.4em;"|EJ Sung | |style="padding:.4em;"|EJ Sung | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 45: | Line 45: | ||
|style="padding:.4em;" rowspan=1|2022/08/11 | |style="padding:.4em;" rowspan=1|2022/08/11 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-23 |
|style="padding:.4em;"|IS Choi | |style="padding:.4em;"|IS Choi | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 52: | Line 52: | ||
|style="padding:.4em;" rowspan=1|2022/08/04 | |style="padding:.4em;" rowspan=1|2022/08/04 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-22 |
|style="padding:.4em;"|SB Baek | |style="padding:.4em;"|SB Baek | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 59: | Line 59: | ||
|style="padding:.4em;" rowspan=1|2022/07/28 | |style="padding:.4em;" rowspan=1|2022/07/28 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-21 |
|style="padding:.4em;"|JH Cha | |style="padding:.4em;"|JH Cha | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 66: | Line 66: | ||
|style="padding:.4em;" rowspan=1|2022/07/21 | |style="padding:.4em;" rowspan=1|2022/07/21 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-20 |
|style="padding:.4em;"|JW Yu | |style="padding:.4em;"|JW Yu | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 73: | Line 73: | ||
|style="padding:.4em;" rowspan=1|2022/07/14 | |style="padding:.4em;" rowspan=1|2022/07/14 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-19 |
|style="padding:.4em;"|IS Choi | |style="padding:.4em;"|IS Choi | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 80: | Line 80: | ||
|style="padding:.4em;" rowspan=1|2022/07/07 | |style="padding:.4em;" rowspan=1|2022/07/07 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-18 |
|style="padding:.4em;"|EJ Sung | |style="padding:.4em;"|EJ Sung | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 89: | Line 89: | ||
|style="padding:.4em;" rowspan=1|2022/06/23 | |style="padding:.4em;" rowspan=1|2022/06/23 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-17 |
|style="padding:.4em;"|SB Baek | |style="padding:.4em;"|SB Baek | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 96: | Line 96: | ||
|style="padding:.4em;" rowspan=1|2022/06/09 | |style="padding:.4em;" rowspan=1|2022/06/09 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-16 |
|style="padding:.4em;"|JH Cha | |style="padding:.4em;"|JH Cha | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 103: | Line 103: | ||
|style="padding:.4em;" rowspan=1|2022/06/02 | |style="padding:.4em;" rowspan=1|2022/06/02 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-15 |
|style="padding:.4em;"|JW Yu | |style="padding:.4em;"|JW Yu | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 110: | Line 110: | ||
|style="padding:.4em;" rowspan=1|2022/05/19 | |style="padding:.4em;" rowspan=1|2022/05/19 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-14 |
|style="padding:.4em;"|EJ Sung | |style="padding:.4em;"|EJ Sung | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 117: | Line 117: | ||
|style="padding:.4em;" rowspan=1|2022/05/12 | |style="padding:.4em;" rowspan=1|2022/05/12 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-13 |
|style="padding:.4em;"|IS Choi | |style="padding:.4em;"|IS Choi | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 124: | Line 124: | ||
|style="padding:.4em;" rowspan=1|2022/04/07 | |style="padding:.4em;" rowspan=1|2022/04/07 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-12 |
|style="padding:.4em;"|SB Baek | |style="padding:.4em;"|SB Baek | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 131: | Line 131: | ||
|style="padding:.4em;" rowspan=1|2022/03/25 | |style="padding:.4em;" rowspan=1|2022/03/25 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-11 |
|style="padding:.4em;"|JH Cha | |style="padding:.4em;"|JH Cha | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 138: | Line 138: | ||
|style="padding:.4em;" rowspan=1|2022/03/18 | |style="padding:.4em;" rowspan=1|2022/03/18 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-10 |
|style="padding:.4em;"|JW Yu | |style="padding:.4em;"|JW Yu | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 145: | Line 145: | ||
|style="padding:.4em;" rowspan=1|2022/03/04 | |style="padding:.4em;" rowspan=1|2022/03/04 | ||
|style="padding:.4em;" rowspan=1|Single-cell | |style="padding:.4em;" rowspan=1|Single-cell | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-9 |
|style="padding:.4em;"|EJ Sung | |style="padding:.4em;"|EJ Sung | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
[https://pubmed.ncbi.nlm.nih.gov/34852236/ Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses] | [https://pubmed.ncbi.nlm.nih.gov/34852236/ Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=1|2022/02/25 | ||
+ | |style="padding:.4em;" rowspan=1|Single-cell | ||
+ | |style="padding:.4em;"|22-8 | ||
+ | |style="padding:.4em;"|SB Baek | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://pubmed.ncbi.nlm.nih.gov/34930412/ MultiMAP: dimensionality reduction and integration of multimodal data] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=1|2022/02/18 | ||
+ | |style="padding:.4em;" rowspan=1|Single-cell | ||
+ | |style="padding:.4em;"|22-7 | ||
+ | |style="padding:.4em;"|IS Choi | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://www.biorxiv.org/content/10.1101/2020.10.19.345983v2 CellRank for directed single-cell fate mapping] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=1|2022/02/11 | ||
+ | |style="padding:.4em;" rowspan=1|Single-cell | ||
+ | |style="padding:.4em;"|22-6 | ||
+ | |style="padding:.4em;"|JH Cha | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://pubmed.ncbi.nlm.nih.gov/34653365/ Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=1|2022/02/04 | ||
+ | |style="padding:.4em;" rowspan=1|Single-cell | ||
+ | |style="padding:.4em;"|22-5 | ||
+ | |style="padding:.4em;"|IS Choi | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://pubmed.ncbi.nlm.nih.gov/34390642/ Chromatin and gene-regulatory dynamics of the developing human cerebral cortex at single-cell resolution] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=1|2022/01/28 | ||
+ | |style="padding:.4em;" rowspan=1|Single-cell | ||
+ | |style="padding:.4em;"|22-4 | ||
+ | |style="padding:.4em;"|EJ Sung | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://pubmed.ncbi.nlm.nih.gov/34767762/ Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=1|2022/01/28 | ||
+ | |style="padding:.4em;" rowspan=1|Single-cell | ||
+ | |style="padding:.4em;"|22-3 | ||
+ | |style="padding:.4em;"|JH Cha | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://pubmed.ncbi.nlm.nih.gov/34914499/ Pan-cancer single-cell landscape of tumor-infiltrating T cells] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=1|2022/01/14 | ||
+ | |style="padding:.4em;" rowspan=1|Single-cell | ||
+ | |style="padding:.4em;"|22-2 | ||
+ | |style="padding:.4em;"|JW Yu | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://pubmed.ncbi.nlm.nih.gov/34597583/ Atlas of clinically distinct cell states and ecosystems across human solid tumors] | ||
+ | |- | ||
+ | |style="padding:.4em;" rowspan=1|2022/01/07 | ||
+ | |style="padding:.4em;" rowspan=1|Single-cell | ||
+ | |style="padding:.4em;"|22-1 | ||
+ | |style="padding:.4em;"|SB Baek | ||
+ | |style="padding:.4em;text-align:left"| | ||
+ | [https://pubmed.ncbi.nlm.nih.gov/34489465/ Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse] | ||
|} | |} | ||
+ | |||
{|class=wikitable style="text-align:center;" | {|class=wikitable style="text-align:center;" | ||
− | |+style="text-align:left;font-size:12pt" | 2022 | + | |+style="text-align:left;font-size:12pt" | 2022 Microbiome |
|- | |- | ||
!scope="col" style="padding:.4em" | Date | !scope="col" style="padding:.4em" | Date | ||
Line 162: | Line 219: | ||
|style="padding:.4em;" rowspan=1|2022/09/22 | |style="padding:.4em;" rowspan=1|2022/09/22 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-30 |
|style="padding:.4em;"|SH Ahn | |style="padding:.4em;"|SH Ahn | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 169: | Line 226: | ||
|style="padding:.4em;" rowspan=1|2022/09/15 | |style="padding:.4em;" rowspan=1|2022/09/15 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-29 |
|style="padding:.4em;"|HJ Kim | |style="padding:.4em;"|HJ Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 176: | Line 233: | ||
|style="padding:.4em;" rowspan=1|2022/09/08 | |style="padding:.4em;" rowspan=1|2022/09/08 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-28 |
|style="padding:.4em;"|JH Cha | |style="padding:.4em;"|JH Cha | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 183: | Line 240: | ||
|style="padding:.4em;" rowspan=1|2022/09/01 | |style="padding:.4em;" rowspan=1|2022/09/01 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-27 |
|style="padding:.4em;"|NY Kim | |style="padding:.4em;"|NY Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 190: | Line 247: | ||
|style="padding:.4em;" rowspan=1|2022/08/25 | |style="padding:.4em;" rowspan=1|2022/08/25 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-26 |
|style="padding:.4em;"|JY Ma | |style="padding:.4em;"|JY Ma | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 197: | Line 254: | ||
|style="padding:.4em;" rowspan=1|2022/08/18 | |style="padding:.4em;" rowspan=1|2022/08/18 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-25 |
|style="padding:.4em;"|SH Lee | |style="padding:.4em;"|SH Lee | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 204: | Line 261: | ||
|style="padding:.4em;" rowspan=1|2022/08/11 | |style="padding:.4em;" rowspan=1|2022/08/11 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-24 |
|style="padding:.4em;"|SH Ahn | |style="padding:.4em;"|SH Ahn | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 211: | Line 268: | ||
|style="padding:.4em;" rowspan=1|2022/08/04 | |style="padding:.4em;" rowspan=1|2022/08/04 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-23 |
|style="padding:.4em;"|HJ Kim | |style="padding:.4em;"|HJ Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 218: | Line 275: | ||
|style="padding:.4em;" rowspan=1|2022/07/28 | |style="padding:.4em;" rowspan=1|2022/07/28 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-22 |
|style="padding:.4em;"|JH Cha | |style="padding:.4em;"|JH Cha | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 225: | Line 282: | ||
|style="padding:.4em;" rowspan=1|2022/07/21 | |style="padding:.4em;" rowspan=1|2022/07/21 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-21 |
|style="padding:.4em;"|NY Kim | |style="padding:.4em;"|NY Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 232: | Line 289: | ||
|style="padding:.4em;" rowspan=1|2022/07/14 | |style="padding:.4em;" rowspan=1|2022/07/14 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-20 |
|style="padding:.4em;"|JY Ma | |style="padding:.4em;"|JY Ma | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 239: | Line 296: | ||
|style="padding:.4em;" rowspan=1|2022/07/07 | |style="padding:.4em;" rowspan=1|2022/07/07 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-19 |
|style="padding:.4em;"|SH Lee | |style="padding:.4em;"|SH Lee | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 247: | Line 304: | ||
|style="padding:.4em;" rowspan=1|2022/06/24 | |style="padding:.4em;" rowspan=1|2022/06/24 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-18 |
|style="padding:.4em;"|SH Ann | |style="padding:.4em;"|SH Ann | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 254: | Line 311: | ||
|style="padding:.4em;" rowspan=1|2022/06/10 | |style="padding:.4em;" rowspan=1|2022/06/10 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-17 |
|style="padding:.4em;"|HJ Kim | |style="padding:.4em;"|HJ Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 261: | Line 318: | ||
|style="padding:.4em;" rowspan=1|2022/06/03 | |style="padding:.4em;" rowspan=1|2022/06/03 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-16 |
|style="padding:.4em;"|JH Cha | |style="padding:.4em;"|JH Cha | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 268: | Line 325: | ||
|style="padding:.4em;" rowspan=1|2022/05/27 | |style="padding:.4em;" rowspan=1|2022/05/27 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-15 |
|style="padding:.4em;"|NY Kim | |style="padding:.4em;"|NY Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 275: | Line 332: | ||
|style="padding:.4em;" rowspan=1|2022/05/20 | |style="padding:.4em;" rowspan=1|2022/05/20 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-14 |
|style="padding:.4em;"|MY Ma | |style="padding:.4em;"|MY Ma | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 282: | Line 339: | ||
|style="padding:.4em;" rowspan=1|2022/05/13 | |style="padding:.4em;" rowspan=1|2022/05/13 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-13 |
|style="padding:.4em;"|SH Lee | |style="padding:.4em;"|SH Lee | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 289: | Line 346: | ||
|style="padding:.4em;" rowspan=1|2022/04/08 | |style="padding:.4em;" rowspan=1|2022/04/08 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-12 |
|style="padding:.4em;"|SH Ahn | |style="padding:.4em;"|SH Ahn | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 296: | Line 353: | ||
|style="padding:.4em;" rowspan=1|2022/04/01 | |style="padding:.4em;" rowspan=1|2022/04/01 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-11 |
|style="padding:.4em;"|HJ Kim | |style="padding:.4em;"|HJ Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 303: | Line 360: | ||
|style="padding:.4em;" rowspan=1|2022/03/18 | |style="padding:.4em;" rowspan=1|2022/03/18 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-10 |
|style="padding:.4em;"|JH Cha | |style="padding:.4em;"|JH Cha | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 310: | Line 367: | ||
|style="padding:.4em;" rowspan=1|2022/03/04 | |style="padding:.4em;" rowspan=1|2022/03/04 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-9 |
|style="padding:.4em;"|JY Ma | |style="padding:.4em;"|JY Ma | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
[https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01011-3 Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling] | [https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01011-3 Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling] | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|style="padding:.4em;" rowspan=1|2022/02/25 | |style="padding:.4em;" rowspan=1|2022/02/25 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-8 |
|style="padding:.4em;"|NY Kim | |style="padding:.4em;"|NY Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 403: | Line 381: | ||
|style="padding:.4em;" rowspan=1|2022/02/18 | |style="padding:.4em;" rowspan=1|2022/02/18 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-7 |
|style="padding:.4em;"|SH Lee | |style="padding:.4em;"|SH Lee | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 410: | Line 388: | ||
|style="padding:.4em;" rowspan=1|2022/02/11 | |style="padding:.4em;" rowspan=1|2022/02/11 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-6 |
|style="padding:.4em;"|SH Ahn | |style="padding:.4em;"|SH Ahn | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 417: | Line 395: | ||
|style="padding:.4em;" rowspan=1|2022/02/04 | |style="padding:.4em;" rowspan=1|2022/02/04 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-5 |
|style="padding:.4em;"|JH Cha | |style="padding:.4em;"|JH Cha | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 424: | Line 402: | ||
|style="padding:.4em;" rowspan=1|2022/01/28 | |style="padding:.4em;" rowspan=1|2022/01/28 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-4 |
|style="padding:.4em;"|JY Ma | |style="padding:.4em;"|JY Ma | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 431: | Line 409: | ||
|style="padding:.4em;" rowspan=1|2022/01/28 | |style="padding:.4em;" rowspan=1|2022/01/28 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-3 |
|style="padding:.4em;"|SH Lee | |style="padding:.4em;"|SH Lee | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 438: | Line 416: | ||
|style="padding:.4em;" rowspan=1|2022/01/14 | |style="padding:.4em;" rowspan=1|2022/01/14 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-2 |
|style="padding:.4em;"|HJ Kim | |style="padding:.4em;"|HJ Kim | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| | ||
Line 445: | Line 423: | ||
|style="padding:.4em;" rowspan=1|2022/01/07 | |style="padding:.4em;" rowspan=1|2022/01/07 | ||
|style="padding:.4em;" rowspan=1|Microbiome | |style="padding:.4em;" rowspan=1|Microbiome | ||
− | |style="padding:.4em;"|22- | + | |style="padding:.4em;"|22-1 |
|style="padding:.4em;"|JY Ma | |style="padding:.4em;"|JY Ma | ||
|style="padding:.4em;text-align:left"| | |style="padding:.4em;text-align:left"| |
Revision as of 07:31, 4 July 2022
Date | Team | Paper index |
Presenter | Paper title |
---|---|---|---|---|
2021/11/23 | Single-cell | 21-39 | IS Choi | |
2021/11/16 | Single-cell | 21-38 | SB Back | |
2021/11/09 | Single-cell | 21-37 | JH Cha | |
2021/11/02 | Single-cell | 21-36 | SB Baek |
Functional Inference of Gene Regulation using Single-Cell Multi-Omics |
2021/10/26 | Single-cell | 21-35 | IS Choi | |
2021/10/19 | Single-cell | 21-34 | JH Cha | |
2021/10/05 | Single-cell | 21-33 | JH Cha |
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma |
2021/09/28 | Single-cell | 21-32 | SB Baek | |
2021/09/14 | Single-cell | 21-31 | IS Choi | |
2021/09/07 | Single-cell | 21-30 | JH Cha |
A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer |
2021/08/31 | Single-cell | 21-29 | IS Choi |
Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma |
2021/08/24 | Single-cell | 21-28 | SB Baek |
Interpreting type 1 diabetes risk with genetics and single-cell epigenomics |
Date | Team | Paper index |
Presenter | Paper title |
---|---|---|---|---|
2021/02/22 | Single-cell | 21-8 | IS Choi |
Functional CRISPR dissection of gene networks controlling human regulatory T cell identity |
21-7 | JH Cha |
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy | ||
2021/02/15 | Single-cell | 21-6 | SB Baek | |
21-5 | IS Choi |
Trajectory-based differential expression analysis for single-cell sequencing data | ||
2021/02/08 | Single-cell | 21-4 | SB Baek |
Genetic determinants of co-accessible chromatin regions in activated T cells across humans |
21-3 | JH Cha |
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer | ||
2021/02/01 | Single-cell | 21-2 | JW Cho | |
21-1 | JW Cho |